(Total Views: 253)
Posted On: 11/05/2017 5:59:47 PM
Post# of 72440
1/13/2016 - $0.95 (low)
5/2/2016 - $1.87 (high)
2016 Potential Catalyst
1. P: Phase 2a top-line data - Q2
P Phase 2a Timelines
3/17/2016 - Last patient visit
3/17/2016 - Run-up started with +29% on ~900K volume ($1.56 closing price)
3/18/2016 - Run-up continued with +14% on ~600K volume ($1.78 closing price)
5/24/2016 - Top-line result
What tax-loss selling?
11/01/2016 - $1.16
12/30/2016 - $1.16
5/10/2017 - $0.63 (low)
2017 high - ?
2017 Potential Catalysts
1. B-OM: top-line data - November/December
2. P: Phase 2b top-line data - December/January
3. K-OC: interim data - Q4
5/2/2016 - $1.87 (high)
2016 Potential Catalyst
1. P: Phase 2a top-line data - Q2
P Phase 2a Timelines
3/17/2016 - Last patient visit
3/17/2016 - Run-up started with +29% on ~900K volume ($1.56 closing price)
3/18/2016 - Run-up continued with +14% on ~600K volume ($1.78 closing price)
5/24/2016 - Top-line result
What tax-loss selling?
11/01/2016 - $1.16
12/30/2016 - $1.16
5/10/2017 - $0.63 (low)
2017 high - ?
2017 Potential Catalysts
1. B-OM: top-line data - November/December
2. P: Phase 2b top-line data - December/January
3. K-OC: interim data - Q4
(0)
(0)
Scroll down for more posts ▼
